[Trial of pivalone in radiation-induced mucous membrane inflammation in E.N.T].
D000523:Algestone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000463:Algestone Acetophenide / Q000031:analogs & derivatives*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D009061:Mouth Mucosa / Q000528:radiation effects; D009092:Mucous Membrane / Q000528:radiation effects*; D009369:Neoplasms / Q000532:radiotherapy*; D010038:Otorhinolaryngologic Diseases / Q000532:radiotherapy*; D011832:Radiation Injuries / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D000523:Algestone; D000463:Algestone Acetophenide
Essai Pivalone dans le traitement des radiomucites O.R.L.